| UHC UMR Medical and Drug | Genetic Testing for Hereditary Cancer – Commercial and Individual Exchange Medical Policy | 2026-07-01 |
| UHC UMR Medical and Drug | Habilitation and Rehabilitation Therapy (Occupational, Physical, and Speech) – Commercial and Individual Exchange Medical Policy | 2026-07-01 |
| UHC UMR Medical and Drug | Immune Globulin (IVIG and SCIG) – Commercial Medical Benefit Drug Policy | 2026-07-01 |
| UHC UMR Medical and Drug | Implanted Spinal Drug Delivery Systems – Commercial and Individual Exchange Medical Policy | 2026-07-01 |
| UHC UMR Medical and Drug | Office-Based Procedures – Site of Service – Commercial and Individual Exchange Medical Policy | 2026-07-01 |
| UHC UMR Medical and Drug | Ophthalmologic Vascular Endothelial Growth Factor (VEGF) Inhibitors – Commercial Medical Benefit Drug Policy | 2026-07-01 |
| UHC UMR Medical and Drug | Panniculectomy Surgery – Commercial and Individual Exchange Medical Policy | 2026-07-01 |
| UHC UMR Medical and Drug | Pharmacogenetic Panel Testing – Commercial and Individual Exchange Medical Policy | 2026-07-01 |
| UHC UMR Medical and Drug | Preventive Care Services – Commercial and Individual Exchange Medical Policy | 2026-07-01 |
| UHC UMR Medical and Drug | Provider Administered Drugs – Preferred Products – Commercial Medical Benefit Drug Policy | 2026-07-01 |